Ads
related to: Atopic Dermatitis Treatment- Before & After Photos
See the Before and After of What
A Treatment Option Can Do For You.
- Clinical Trial Results
See Results For A Treatment
For Eczema (Atopic Dermatitis).
- Eczema Causes
Learn More About The Causes
Of Eczema (Atopic Dermatitis).
- Atopic Dermatitis
Learn About Causes, Symptoms,
& An Oral Treatment Option.
- What Is Eczema?
Find Important Facts & Information
To Understand Atopic Dermatitis.
- Sign Up for Info
Get Updates, Answers, and Resources
For Treatment Support
- Before & After Photos
Search results
ASLAN expands research on atopic dermatitis treatment By Investing.com
Investing.com· 2 days agoASLAN Pharmaceuticals (NASDAQ:ASLN), a clinical-stage biopharmaceutical company, has announced a new...
Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review
Medscape· 4 days agoA decision on approval is expected in the fourth quarter of 2024.
How to Spot and Take Care of Your Newborn’s Rash
Verywell Health via Yahoo News· 5 days agoIf it persists, your provider may prescribe a cream or shampoo. Eczema Eczema (atopic dermatitis) makes the skin itchy, dry, and scaly, leading to red...
Incyte shares dip after earnings, guidance miss
Investing.com· 4 days agoIncyte (NASDAQ: INCY ) Corporation (NASDAQ:INCY), a global biopharmaceutical company, reported first-quarter earnings that fell short of Wall Street...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 1 day agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 4 days agoOpzelura cream 1.5% is approved for the topical treatment of non-segmental vitiligo in adult and...
Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After...
Fontana Herald News· 2 days agoNektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter 2024 on Thursday, May 9, 2024, after the close of U.S.-based financial markets. Howard Robin, President ...
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoKymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript May 3, 2024 Kymera...
Regeneron’s stock rallies as pipeline prospects outweigh earnings miss
Market Watch· 2 days agoThe revenue shortfall was partly due to a decline in sales of the company’s blockbuster eye drug...
Gene expression analyses identify potential drivers of chronic allergic inflammation
Medical Xpress· 4 days agoCurrently, most therapies for allergic diseases require lifelong treatment. Allergic reactions, characterized by ongoing (type 2) inflammation in response to chronic antigen ...
Ads
related to: Atopic Dermatitis Treatment
